← Browse by Condition
Medical Condition
safety issues
Total Trials
3
Recruiting Now
3
Trial Phases
EARLY_Phase 1, Phase 4
NCT06509490
Recruiting
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
Enrollment
9 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT06189170 EARLY_Phase 1
Recruiting
Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients
Enrollment
88 pts
Location
United Kingdom
Sponsor
Kariya Pharmaceuticals
NCT05164263 Phase 4
Recruiting
Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
Enrollment
2,000 pts
Location
Afghanistan, Kenya, ...
Sponsor
Getz Pharma